Login to Your Account

Proximagen Pulls in £50M to Expand CNS Offerings

By Nuala Mora

Wednesday, June 10, 2009
In one of the largest UK biotech fundings of the past 10 years, Proximagen Neurosciences plc is raising £50 million (US$82.5 million) in a nondiscounted placing, a success that will be a shot in the arm for the sector as a whole. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription